These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2654919)

  • 1. [Content of vasopressin and beta2-microglobulin in the blood in patients with diabetes mellitus type II accompanied by microangiopathy].
    Livshits IB; Kostiuk KL; Sherstiuk GB
    Probl Endokrinol (Mosk); 1989; 35(1):15-8. PubMed ID: 2654919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lipid composition of thrombocytes in diabetes mellitus depending on the degree of microangiopathy].
    Kasimova GM; Mirtalipov DT; Abidov AA; Akbarov VZ
    Probl Endokrinol (Mosk); 1987; 33(4):20-3. PubMed ID: 3658945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of macrovascular complications of type 2 diabetes mellitus with serum magnesium levels.
    Agrawal P; Arora S; Singh B; Manamalli A; Dolia PB
    Diabetes Metab Syndr; 2011; 5(1):41-4. PubMed ID: 22814841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The relationship between concentration of growth hormone in serum and microangiopathy in patients with diabetes mellitus].
    Chen M; Yu W; Hu S
    Zhonghua Yi Xue Za Zhi; 1997 Oct; 77(10):765-7. PubMed ID: 9772523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheological leukocyte indexes in diabetes mellitus type II.
    Perego MA; Danese C; Volpe MS; Zavattaro E; Calisi L
    Ann Cardiol Angeiol (Paris); 1992 Dec; 41(10):A75-80. PubMed ID: 1300912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between the level of plasma D-dimer and diabetic microangiopathy].
    Long ZF; Qu GY; Xu M
    Hunan Yi Ke Da Xue Xue Bao; 2001 Oct; 26(5):434-6. PubMed ID: 12536492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticardiolipin and anti-beta2 glycoprotein I antibody concentrations in patients with type 2 diabetes mellitus.
    Tarkun I; Hacihanefioğlu A; Tarkun P; Cetinarslan B; Cantürk Z
    Diabetes Res Clin Pract; 2005 Jun; 68(3):181-7. PubMed ID: 15936458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphofunctional changes in the erythrocytes in diabetes mellitus].
    Efimov AS; Pleshanov EV; Gogina IF
    Probl Endokrinol (Mosk); 1988; 34(2):13-5. PubMed ID: 3393498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood and plasma viscosity and the distance of intermittent claudication in patients with type II diabetes and thrombophlebitis].
    Turczyński B; Sroczyński J; Matyszczyk B; Szczesny S; Strugala M
    Wiad Lek; 1990 Jun; 43(11):483-8. PubMed ID: 2219912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The content of stable forms of prostacyclin I2 and thromboxane A2 in the blood plasma in diabetic angiopathies].
    Sergienko AA
    Probl Endokrinol (Mosk); 1991; 37(4):24-6. PubMed ID: 1788186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of serum beta-2-microglobulin as a predictor of diabetic complications in patients with type 2 diabetes without renal impairment.
    Kim MK; Yun KJ; Chun HJ; Jang EH; Han KD; Park YM; Baek KH; Song KH; Cha BY; Park CS; Kwon HS
    Diabetes Metab; 2014 Dec; 40(6):459-65. PubMed ID: 25303803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Markers of vascular inflammation in diabetes mellitus type 2 with hypertension and albuminuria].
    Gómez-Fernández P; Ruiz A; Conde MR; Campos R; Vargas JC; Almaraz M
    Nefrologia; 2004; 24(1):67-9. PubMed ID: 15083960
    [No Abstract]   [Full Text] [Related]  

  • 14. Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy.
    Mastej K; Adamiec R
    Acta Diabetol; 2008 Sep; 45(3):183-90. PubMed ID: 18496641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications.
    Erem C; Hacihasanoğlu A; Celik S; Ovali E; Ersöz HO; Ukinç K; Deger O; Telatar M
    Med Princ Pract; 2005; 14(1):22-30. PubMed ID: 15608477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between the serum level of C-peptide and risk factors for coronary heart disease and diabetic microangiopathy in patients with type-2 diabetes mellitus.
    Inukai T; Matsutomo R; Tayama K; Aso Y; Takemura Y
    Exp Clin Endocrinol Diabetes; 1999; 107(1):40-5. PubMed ID: 10077354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated beta2-glycoprotein I-low-density lipoprotein levels are associated with the presence of diabetic microvascular complications.
    Yu R; Yuan Y; Niu D; Song J; Liu T; Wu J; Wang J
    J Diabetes Complications; 2015; 29(1):59-63. PubMed ID: 25449980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between circulating vascular cell adhesion molecule-1 and vascular complications in type 2 diabetes mellitus].
    Gu W; Xu X; Zhu Y
    Zhonghua Nei Ke Za Zhi; 2001 Jul; 40(7):456-8. PubMed ID: 11798614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of proinflammatory cytokines in the development and progression of micro- and macroangiopathies in patients with type 2 diabetes mellitus].
    Nelaeva AA; Khasanova IuV; Khobotova ES
    Angiol Sosud Khir; 2013; 19(3):9-13. PubMed ID: 24300485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Levels of various pituitary and pancreatic hormones in the blood of patients with non-insulin-dependent diabetes mellitus].
    Perelygina AA; Golikova AA; Zin'ko NV
    Probl Endokrinol (Mosk); 1984; 30(5):10-3. PubMed ID: 6390423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.